Literature DB >> 32468959

The Price to Consumers of Generic Pharmaceuticals: Beyond the Headlines.

Richard G Frank1,2, Andrew Hicks1, Ernst R Berndt2,3.   

Abstract

Generic drug prices have received a great deal of attention in the past few years. Many agencies have conducted investigations into the pricing patterns for generic drugs. Price spikes for several specific generic drugs have also been widely reported in the media. Today, 90% of all retail prescriptions sold in the United States are generic drugs. Thus, these prices affect affordability of prescription drugs. We construct two Laspeyres chained price indexes for generic prescription drugs. The first reflects direct out-of-pocket payments by consumers to pharmacies for dispensing generic prescription drugs. The second measures the total price received by the pharmacy (the direct out-of-pocket payment plus the price paid to the pharmacy by the insurer). The chained direct out-of-pocket consumer price index we construct shows a roughly 50% decline for generic prescription drugs between 2007 and 2016. The total consumer price index for generic prescription drugs fell by nearly 80%.

Entities:  

Keywords:  affordability; generic drugs; prescription drugs; prices

Mesh:

Substances:

Year:  2020        PMID: 32468959     DOI: 10.1177/1077558720921100

Source DB:  PubMed          Journal:  Med Care Res Rev        ISSN: 1077-5587            Impact factor:   3.929


  2 in total

1.  The Evolution of Supply and Demand in Markets for Generic Drugs.

Authors:  Richard G Frank; Thomas G McGuire; Ian Nason
Journal:  Milbank Q       Date:  2021-06-01       Impact factor: 6.237

2.  Medicare Part D Plans Rarely Cover Brand-Name Drugs When Generics Are Available.

Authors:  Stacie B Dusetzina; Juliette Cubanski; Leonce Nshuti; Sarah True; Jack Hoadley; Drew Roberts; Tricia Neuman
Journal:  Health Aff (Millwood)       Date:  2020-08       Impact factor: 9.048

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.